1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 20 to 70 Sponsor: Protocol IDs: MSHMC-REN-2
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NCI-D79-019-073, BUCRC-751
|
|
3.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: E-2193, NCI-P01-0194, NCT00026286, ECOG-E2193
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N99C7, NCI-P02-0204, NCT00030914
|
|
5.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDA-U/u17
|
|
6.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: GOG-48, GOG-7941
|
|
7.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-7956
|
|
8.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 to 75 Sponsor: Protocol IDs: BGSM-89285, NCI-V85-0243
|
|
9.
|
Phase: Phase III Type: Treatment Status: Closed Age: any age Sponsor: Protocol IDs: COSA-UK-NZ-E1/82
|
|
10.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: EORTC-10802
|
|
11.
|
Phase: Phase III Type: Treatment Status: Closed Age: over 18 Sponsor: Protocol IDs: POA-74185
|
|
12.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-81B
|
|
13.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-81C
|
|
14.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-81D
|
|
15.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-81E
|
|
16.
|
Phase: Phase III Type: Treatment Status: Closed Age: postmenopausal Sponsor: Protocol IDs: EORTC-10863
|
|
17.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: GOG-81
|
|
18.
|
Phase: Phase III Type: Treatment Status: Closed Age: postmenopausal Sponsor: Protocol IDs: COSA-ANZ-8613
|
|
19.
|
Phase: Phase III Type: Treatment Status: Closed Age: pre/postmenopausal Sponsor: Protocol IDs: CRC-TU-BR3007, EU-90036
|
|
20.
|
Phase: Phase III Type: Treatment Status: Closed Age: any age Sponsor: Protocol IDs: MRC-RE01, EU-91021
|
|
21.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CDR0000468571, LEONB-PERCY-QUATTRO, EU-20605, LEONB-ET99-058, ROCHE-LEONB-PERCY-QUATTRO, CHIRON-LEONB-PERCY-QUATTRO, NCT00416429
|
|
22.
|
Phase: Phase III Type: Prevention, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000065314, CALGB-49901, S9630, U10CA037429, U10CA032102, SWOG-S9630, SWOG-9630, NCT00002920
|
|
23.
|
Phase: Phase II Type: Prevention Status: Completed Age: Not specified Sponsor: NCI Protocol IDs: GOG-0167, NCT00003179
|
|
24.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: SEG-GU-P33
|
|
25.
|
Phase: Phase II Type: Prevention Status: Closed Age: 25 to 50 Sponsor: NCI, Other Protocol IDs: ID01-340, P30CA016672, MDA-ID-01340, NCI-P02-0218, CDR0000069277, TX035, N01-CN-05127, NCT00033358
|